Hepsera

Active Ingredient(s): Adefovir
FDA Approved: * September 20, 2002
Pharm Company: * GILEAD
Category: Hepatitis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Hepsera Overview

Adefovir is a prescription medicine used to treat (chronic) infections with hepatitis B virus. A prodrug form of adefovir was previously called bis-POM PMEA, with trade names Preveon and Hepsera. It is an orally administered nucleotide analog reverse-transcriptase inhibitor (ntRTI). It can be formulated as the pivoxil prodrug adefovir dipivoxil. Contents 1 Uses 2 History 3 Mechanism of action 4 References 5 External links Uses It is used for treatment of hepatitis B [1&#...

Read more Hepsera Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Adefovir

Recent Hepsera Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Adefovir
  • Tablet: 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Hepsera: (2 results)

Sorted by National Drug Code
  • 46014-0501 Hepsera 10 mg Oral Tablet by Excella Gmbh
  • 61958-0501 Hepsera 10 mg Oral Tablet by Gilead Sciences, Inc.

Other drugs which contain Adefovir or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA